Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Nu-Med Plus (NUMD) Shares Outstanding (Weighted Average) (2016 - 2021)

Nu-Med Plus' Shares Outstanding (Weighted Average) history spans 10 years, with the latest figure at $79.3 million for Q3 2021.

  • Quarterly results put Shares Outstanding (Weighted Average) at $79.3 million for Q3 2021, up 62.71% from a year ago — trailing twelve months through Sep 2021 was $79.3 million (up 62.71% YoY), and the annual figure for FY2020 was $54.5 million, up 19.69%.
  • Shares Outstanding (Weighted Average) for Q3 2021 was $79.3 million at Nu-Med Plus, roughly flat from $79.3 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $79.3 million in Q2 2021 to a low of $34.2 million in Q2 2017.
  • The 5-year median for Shares Outstanding (Weighted Average) is $45.1 million (2019), against an average of $48.1 million.
  • The sharpest move saw Shares Outstanding (Weighted Average) fell 6.16% in 2017, then surged 70.29% in 2021.
  • Year by year, Shares Outstanding (Weighted Average) stood at $37.5 million in 2017, then rose by 11.55% to $41.8 million in 2018, then rose by 9.0% to $45.5 million in 2019, then rose by 19.69% to $54.5 million in 2020, then soared by 45.51% to $79.3 million in 2021.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $79.3 million, $79.3 million, and $79.3 million for Q3 2021, Q2 2021, and Q1 2021 respectively.